EUVIMEDEUVIMED entdecken
Open Access

Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC

Ying Ma, Bateer Han, Qin Yu, Nashunbayaer Zha, Zhiyuan Deng, Junguo Liang, Rong Yu

Aging · 2024

DOI: 10.18632/aging.205517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Ying Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, Inner Mongolia Autonomous Region, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) is characterized by stronger metastatic ability and worse prognosis. In NSCLC, hypoxia is a major cause of invasion and metastasis through promoting angiogenesis. In present study, NSCLC cell clusters were extracted from single cell-sequencing dataset GSE131907, which were combined with hypoxia-related genes to group clusters. qRT-PCR and western blot were used to validate the expression of target gene. Nine NSCLC clusters were extracted, which were divided into two hypoxia-related subgroups, C1 and C2. Totally 101 differentially expressed prognostic genes were identified between subgroups. Of which, VDAC2 showed excellent prognostic value for NSCLC and was selected for further analysis. VDAC2 was upregulated in tumor samples in TCGA and was correlated with advanced stages. In vitro experiments validated this trend. Five crucial immune cells showed differential infiltration proportions between high and low VDAC2 expression groups. VDAC2 knockdown significantly inhibited the proliferation and invasion ability of NSCLC cells. Integrating single cell and bulk sequencing data as well as wet lab experiments, hypoxia-related VDAC2 exhibited important prognostic value and showed the promise of becoming immune-therapy target in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsHumansCell Line, TumorPrognosisSequence Analysis, RNAHypoxiaVoltage-Dependent Anion Channel 2

Stichwörter der Autor:innen

VDAC2immune landscapenon-small cell lung cancerprognosissingle-cell transcriptome

Substanzen

MicroRNAsVDAC2 protein, humanVoltage-Dependent Anion Channel 2

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, Inner Mongolia Autonomous Region, China.
  • Department of Thoracic Surgery, Peking University Cancer Hospital (Inner Mongolia Campus) and Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot 010020, Inner Mongolia Autonomous Region, China.
  • Department of Radiation Oncology, Peking University Cancer Hospital (Inner Mongolia Campus) and Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot 010020, Inner Mongolia Autonomous Region, China.

Zitieren

APA

Ma, Y., Han, B., Yu, Q., Zha, N., Deng, Z., Liang, J., & Yu, R. (2024). Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC. Aging. https://doi.org/10.18632/aging.205517

Vancouver

Ma Y, Han B, Yu Q, Zha N, Deng Z, Liang J, et al. Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC. Aging. 2024. doi:10.18632/aging.205517

BibTeX
@article{Ma2024,
  author = {Ma, Ying and Han, Bateer and Yu, Qin and Zha, Nashunbayaer and Deng, Zhiyuan and Liang, Junguo and Yu, Rong},
  title = {Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205517}
}
Kostenlos starten →